These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7407434)

  • 1. Radiation biology and potential therapeutic applications of radionuclides.
    Hofer KG
    Bull Cancer; 1980; 67(3):343-53. PubMed ID: 7407434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic applications of Auger and alpha emitting radionuclides.
    Bloomer WD; McLaughlin WH; Adelstein SJ; Wolf AP
    Strahlentherapie; 1984 Dec; 160(12):755-7. PubMed ID: 6393458
    [No Abstract]   [Full Text] [Related]  

  • 3. Radioactive derivatives of 2-methyl-1, 4-naphthoquinol bis (diphosphate salt) as anti-cancer drugs with high LET radiations.
    Mitchell JS; Brown I; Carpenter RN
    Prog Clin Biol Res; 1984; 166():327-35. PubMed ID: 6504938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some considerations of physical and biological factors in radiotherapy with high-LET radiations including heavy particles, pi mesons, and fast neutrons.
    Tobias CA; Lyman JT; Lawrence JH
    Prog At Med; 1971; 3():167-218. PubMed ID: 5004402
    [No Abstract]   [Full Text] [Related]  

  • 5. Photon activation therapy.
    Fairchild RG; Bond VP
    Strahlentherapie; 1984 Dec; 160(12):758-63. PubMed ID: 6515666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue dosimetry of liposome-radionuclide complexes for internal radiotherapy: toward liposome-targeted therapeutic radiopharmaceuticals.
    Kostarelos K; Emfietzoglou D
    Anticancer Res; 2000; 20(5A):3339-45. PubMed ID: 11062762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation.
    Chen Y; Trotti A; Coleman CN; Machtay M; Mirimanoff RO; Hay J; O'brien PC; El-Gueddari B; Salvajoli JV; Jeremic B
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1442-51. PubMed ID: 16414207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Clinical Trials in Radiation Oncology. High LET: heavy particle trials.
    Griffin TW; Wambersie A; Laramore G; Castro J
    Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S83-92. PubMed ID: 2839437
    [No Abstract]   [Full Text] [Related]  

  • 9. [Progress in heavy particle radiotherapy].
    Tsujii H; Tsuji H; Okumura T
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):929-35. PubMed ID: 8002630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An attempt to develop a radioactive drug.
    Mitchell JS
    Clin Radiol; 1965 Oct; 16(4):305-23. PubMed ID: 5842782
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic implications of iodine-125 cytotoxicity.
    Bloomer WD; McLaughlin WH; Adelstein SJ
    Int J Radiat Oncol Biol Phys; 1982 Nov; 8(11):1903-8. PubMed ID: 7153101
    [No Abstract]   [Full Text] [Related]  

  • 12. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RBE of radiations in space and the implications for space travel.
    Edwards AA
    Phys Med; 2001; 17 Suppl 1():147-52. PubMed ID: 11771542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A report on the implementation aspects of the International Atomic Energy Agency's first doctoral coordinated research project, "Management of liver cancer using radionuclide methods with special emphasis on trans-arterial radio-conjugate therapy and internal dosimetry".
    Padhy AK; Dondi M
    Semin Nucl Med; 2008 Mar; 38(2):S5-12. PubMed ID: 18243843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy with alpha-particle emitting radionuclides.
    Zalutsky MR; Pozzi OR
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotargeting agents for cancer therapy.
    Kassis AI
    Expert Opin Drug Deliv; 2005 Nov; 2(6):981-91. PubMed ID: 16296803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for selective targeting of Auger electron emitters to tumor cells.
    O'Donoghue JA
    J Nucl Med; 1996 Apr; 37(4 Suppl):3S-6S. PubMed ID: 8676202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro cytotoxicity of (211)at-astatide and (131)I-iodide to glioma tumor cells expressing the sodium/iodide symporter.
    Carlin S; Akabani G; Zalutsky MR
    J Nucl Med; 2003 Nov; 44(11):1827-38. PubMed ID: 14602867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The radiation biology of boron neutron capture therapy.
    Coderre JA; Morris GM
    Radiat Res; 1999 Jan; 151(1):1-18. PubMed ID: 9973079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radionuclide therapy--a possible way toward an improved treatment of cancer. The obstacle is the shortage of commercially available radionuclides for clinical use].
    Lundqvist H; Carlsson J; Gedda L; Tolmachev V; Garske U; Kairemo K
    Lakartidningen; 2004 Mar; 101(11):1000-2, 1005-6. PubMed ID: 15055121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.